glp 1 medications tirzepatide Study Compares GLP-1 Drugs on Their Benefits, Harms Decoding GLP-1 Weight Loss Medications

This triple-agonist approach, targeting GLP-1, GIP, and glucagon receptors, produced the most dramatic weight loss results seen in any Phase 2 obesity trial

However, despite the Food and Drug Administration recently raising concerns about the side effects of unapproved GLP-1s for weight loss, one-third of GLP-1 users have switched from brand-name to compounded or custom-mixed drugs

We encourage patients to consult with their healthcare provider to fully understand the risks and benefits of compounded medications

Additionally, native GLP-1 increases endothelial function and vasodilation in both diabetic and non-diabetic patients, regardless of alterations in insulin sensitivity

A weekly or biweekly IV session often feels right for basic wellness

Semaglutide is also an FDA-approved weight loss drug